Navigation Links
Amgen Announces Webcast of 2013 Second Quarter Financial Results
Date:7/25/2013

THOUSAND OAKS, Calif., July 25, 2013 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that it will report its second quarter financial results on Tuesday, July 30, 2013, after the close of the U.S. financial markets. The announcement will be followed by a conference call with the investment community at 2:00 p.m. PDT. Participating in the call from Amgen will be Robert A. Bradway, chairman and chief executive officer, and other members of Amgen's senior management team.

Live audio of the conference call will be simultaneously broadcast over the Internet and will be available to members of the news media, investors and the general public.

The webcast of the conference, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com, under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event. 

About Amgen
Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe, effective medicines from lab to manufacturing plant to patient. Amgen therapeutics have changed the practice of medicine, helping people around the world in the fight against serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. For more information, visit www.amgen.com and follow us on

SOURCE Amgen
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Amgen Award For Science Teaching Excellence Honors Outstanding Teachers
2. Amgen Announces Top-Line Results Of Phase 3 Trebananib (AMG 386) TRINOVA-1 Trial In Recurrent Ovarian Cancer
3. Amgen Presents Positive Results From Talimogene Laherparepvec Phase 3 Study In Patients With Metastatic Melanoma
4. Amgen To Webcast Investor Meeting At Upcoming American Society Of Clinical Oncology Annual Meeting
5. Amgen And Astellas Announce Japan Alliance
6. Amgen to Present at the Deutsche Bank 38th Annual Healthcare Conference
7. Amgen To Present At The UBS Global Life Sciences Conference
8. The Zacks Analyst Blog Highlights: Genomic Health, Sanofi, Regeneron Pharmaceuticals, Amgen and Isis Pharmaceuticals
9. Amgen Highlights Data To Be Presented At American Society of Clinical Oncology Annual Meeting
10. Amgen, Hospira and Sandoz Named Among Top Pharmaceutical Companies with Greatest Biosimilar Drug Potential in United States
11. Amgen And Zhejiang Beta Pharma Announce Planned Joint Venture In China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... , July 10, 2014  BC Technical, the largest ... MiE America , Inc., a leading provider of Siemens ... a long-term agreement naming BC Technical as the authorized ... MiE and BC Technical announced today that ... establish BC Technical as the service and systems provider ...
(Date:7/10/2014)... CVS Caremark Corporation (NYSE: CVS ) today announced ... of $0.275 (27.5 cents) per share on the corporation,s common ... holders of record on July 21, 2014. About ... helping people on their path to better health as the ... . Through the company,s more than 7,600 CVS/pharmacy stores; ...
(Date:1/15/2014)... , Jan. 15, 2014  Research and Markets ( http://www.researchandmarkets.com/research/6k27gw/dental ... Consumables Market - Global Industry Analysis, Size, Share, Growth, ... their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ... are used on patients in order to treat dental ...
Breaking Medicine Technology:BC Technical Partners With MiE America To Be Authorized Provider Of Systems & Service 2Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 2Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 3
... COTTAGE, N.Y., June 30 XTL,Biopharmaceuticals Ltd. (Nasdaq: ... patient randomization into its Phase 2b study of Bicifadine,-- ... the,treatment of diabetic neuropathic pain. 350 patients were randomized ... Company expects to,have the last patient complete the study ...
... new understanding of,the role played by the protein ... novel therapies to rebuild muscle tissue,damaged by disease, ... Institute for Cancer Research and Molecular Medicine at ... The researchers reported their findings, "Cdk9-55: A ...
Cached Medicine Technology:XTL Biopharmaceuticals Announces Completion of Patient Randomization Into the Bicifadine Phase 2b Clinical Trial for the Treatment of Diabetic Neuropathic Pain 2XTL Biopharmaceuticals Announces Completion of Patient Randomization Into the Bicifadine Phase 2b Clinical Trial for the Treatment of Diabetic Neuropathic Pain 3International Team Locates Key Player in Muscle Regeneration 2
(Date:7/11/2014)... Biostimulants are widely applied in turf ... ornamentals. These also help turf and ornamentals in absorption ... Turf, ornamentals, and flowers appear healthy and strong as ... increased from the last few years. The most dominating ... Europe, with around 40% share in 2013, and is ...
(Date:7/11/2014)... Researchers from The Miriam Hospital have found that ... significantly higher rates of smoking than those without ... less likely to attempt quitting than those without ... be sufficient for this population. The study and ... print in the American Journal of Public ...
(Date:7/11/2014)... 2014 The Corn Farming ... 2014 on the heels of fresh biofuel demand. The ... dedicate a larger share of their farmland to cultivating ... regulations required the mixing of 5.0% renewable content in ... the United States created a key export market for ...
(Date:7/11/2014)... FRIDAY, July 11, 2014 (HealthDay News) -- Prostate cancer ... disease, receive less effective treatment and die sooner if ... Researchers analyzed data from more than 41,200 American men ... and 2007. They followed them through 2009. Nearly 1,900 ... the two years before their prostate cancer was discovered. ...
(Date:7/11/2014)... 11, 2014 Riverside Health System became the ... in Virginia in late 2012 and now, in partnership with ... residents throughout the Williamsburg and Newport News region. , Also ... and benefits to independent older adults who wish to remain ... safety net of continuing care services as well as control ...
Breaking Medicine News(10 mins):Health News:Biostimulants Market in Turf and Ornamentals is Expected to Reach $ 3.8 Billion by 2018 - New Report by MicroMarket Monitor 2Health News:Biostimulants Market in Turf and Ornamentals is Expected to Reach $ 3.8 Billion by 2018 - New Report by MicroMarket Monitor 3Health News:Miriam Hospital study examines smoking prevalence 2Health News:Corn Farming in Canada Industry Market Research Report Now Available From IBISWorld 2Health News:Corn Farming in Canada Industry Market Research Report Now Available From IBISWorld 3Health News:Depression May Make It Harder to Beat Prostate Cancer 2Health News:Riverside and Williamsburg Landing Partner to Offer First of Its Kind Service to Virginians Who Want to Age in Place 2Health News:Riverside and Williamsburg Landing Partner to Offer First of Its Kind Service to Virginians Who Want to Age in Place 3Health News:Riverside and Williamsburg Landing Partner to Offer First of Its Kind Service to Virginians Who Want to Age in Place 4
... in Care, The experience of Ontario, Canada ... inequities but not education-related disparities in health care ... data on more than 25,558 residents of Ontario, ... covered by government, researchers find patient income levels ...
... related to heart disease, study shows , MONDAY, Sept. 21 ... at higher risk for having a heart attack, especially those ... both seasonal and the pandemic H1N1 swine flu are circulating ... are urged to get a seasonal flu shot and an ...
... of a specific gene variant shows a strong ... (UC) have demonstrated. In addition, the research indicates ... individuals harboring the gene variant can be further ... Stambrook, PhD, a professor in the department of ...
... , , SACRAMENTO, Calif., ... the Twin Rivers Unified School District will be able to ... created jointly by the California Dental Association Foundation, University of ... California HealthCare Foundation with start-up funding from Verizon. , ...
... 21 HTH Worldwide, a global health and safety ... are now available with sickness, accident and medical evacuation ... that include direct payment to participating doctors and hospitals ... the market today limit medical benefits to $25,000 or ...
... MARINA DEL REY, Calif., Sept. 21 Electronic medical records have ... Dr. Richard Merkin, CEO for Heritage Provider Network. HPN and its ... York have been eliminating waste and cutting costs while providing quality ... on the importance of integrating electronic medical records. , , ...
Cached Medicine News:Health News:September/October 2009 Annals of Family Medicine tip sheet 2Health News:September/October 2009 Annals of Family Medicine tip sheet 3Health News:September/October 2009 Annals of Family Medicine tip sheet 4Health News:September/October 2009 Annals of Family Medicine tip sheet 5Health News:September/October 2009 Annals of Family Medicine tip sheet 6Health News:Flu Can Raise Chances of Heart Attack 2Health News:Flu Can Raise Chances of Heart Attack 3Health News:Cancer predisposition from genetic variation shows strong gender bias 2Health News:New Tele-Health Care Project to Provide Dental Care to Underserved Communities in California 2Health News:New Tele-Health Care Project to Provide Dental Care to Underserved Communities in California 3Health News:New Tele-Health Care Project to Provide Dental Care to Underserved Communities in California 4Health News:HTH Worldwide Introduces Trip Protection Insurance With Major Medical Benefits 2Health News:Heritage Provider Network and Dr. Richard Merkin Highlight Cutting Health Care Costs Using Electronic Medical Records 2
Li Brand™ Surgical Hemostat. ("dissecting clamp") For NSV and other procedures....
... for applications such as vasectomy that ... ,The autoclavable handpiece with six-foot cord ... cautery electrodes, allowing the physician to ... wide variety of procedures., ,The 2201 ...
No Scalpel Vasectomy Hemostat 5 1/2" (14cm), smooth sharp point, curved, gold finger rings...
Li Brand™ Ringed Forceps. ("fixation clamp") For NSV and other procedures. Ring diameter approximately 3.5 mm. Manufactured exclusively for AMI to exacting specifications by a German company....
Medicine Products: